Clinical Trial Update: Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating terbinafine for biochemically recurrent prostate cancer. The study is currently recruiting in Switzerland.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Terbinafine (terbinafine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: RECRUITING